A collaboration led by CMS and America’s Health Insurance Plans released 7 core sets of quality measures created to reduce complexity, decrease cost burden, and ensure high-quality care.
A collaboration led by CMS and America’s Health Insurance Plans (AHIP) has resulted in 7 sets of core quality measures created to support quality improvement and provide better alignment.
The measures were developed as part of a broad Core Quality Measures Collaborative of healthcare system participants in an effort to establish measures that will reduce complexity for reporting clinicians, decrease cost burden to consumers and the system, and ensure high-quality care for patients.
“In the U.S. health care system, where we are moving to measure and pay for quality, patients and care providers deserve a uniform approach to measure quality,” CMS Acting Administrator Andy Slavitt said in a statement. “This agreement today will reduce unnecessary burden for physicians and accelerate the country's movement to better quality.”
The core measures released are in the following 7 sets:
The measures will be implemented in several stages. While CMS is already using measures from the core sets, it will implement new core measures while eliminating redundant measures. The Health Care Payment Learning and Action Network will integrate the measures as well. Finally, when contracts come up for renewal, commercial health plans will implement these core sets of measures.
Helen Burstin, MD, MPH, chief scientific officer of the National Quality Forum (NQF), which also participated in the Collaborative’s efforts, called the agreement on core measures sets “an important step” toward making healthcare more effective and efficient.
“Clinicians need fewer and more meaningful measures that reduce the burden of reporting multiple quality measures to different entities and take time away from direct patient care,” she said. “And consumers need measures that provide actionable information to better inform healthcare decisions.”
NQF provided technical assistance and many of the core measures are already endorsed by the organization.
The core measure sets will be reviewed on an ongoing basis and the Collaborative will develop a process to ensure the measure sets reflect the most up-to-date evidence.
“The Collaborative's efforts are a critical step forward in improving health outcomes and quality care for patients,” Carmella Bocchino, executive vice president of AHIP, said in a statement. “This process will ensure measures and reporting are consistent across programs in both the private and public sectors.”
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More